Significance of the invasive strategy after acute myocardial infarction on prognosis and secondary preventive medication: A nationwide study of 6364 women and 11,915 men

Journal of Invasive Cardiology

Volumn 24, Issue 1, 2012, Pages 19-24

  Hvelplund, Anders ^a,b,c   Galatius, Søren ^b,c   Madsen, Mette ^c   Sørensen, Rikke ^b   Madsen, Jan Kyst ^b,c   Iversen, Allan Zeeberg ^b   Tilsted, Hans Henrik ^c,d   Helqvist, Steffen ^e   Mortensen, Poul Erik ^c,f   Nielsen, Per Hostrup ^c,g   Prescott, Eva ^c   Abildstrøm, Steen Zabell ^c  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d AALBORG UNIVERSITY HOSPITAL   (Denmark)

^e Rigshospitalet   (Denmark)

^f ODENSE UNIVERSITY HOSPITAL   (Denmark)

^g AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

acute coronary syndrome; coronary angiography; coronary intervention (PCI); delivery of care; gender

Indexed keywords

ACUTE HEART INFARCTION; ADULT; AGED; ALL CAUSE MORTALITY; ANGIOCARDIOGRAPHY; ARTICLE; COHORT ANALYSIS; FEMALE; HOSPITAL READMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; PROGNOSIS; REVASCULARIZATION; SECONDARY PREVENTION; SURVIVAL TIME; COMPARATIVE STUDY; CORONARY ARTERY BYPASS GRAFT; DENMARK; HEART INFARCTION; LONGITUDINAL STUDY; MIDDLE AGED; OUTCOME ASSESSMENT; RECURRENT DISEASE; REGISTER; SEXUAL DEVELOPMENT; SURVIVAL RATE; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANGIOPLASTY, BALLOON, CORONARY; COHORT STUDIES; CORONARY ANGIOGRAPHY; CORONARY ARTERY BYPASS; DENMARK; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; OUTCOME ASSESSMENT (HEALTH CARE); PROGNOSIS; RECURRENCE; REGISTRIES; SECONDARY PREVENTION; SEX CHARACTERISTICS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84864297891     PISSN: 10423931     EISSN: 15572501     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Andersen HR, Nielsen TT, Rasmussen K, et al. A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction. N Engl J Med. 2003;349(8):733-742. (Pubitemid 37010777)
2. Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study. FRagmin and Fast Revascularisation during InStability in Coronary artery disease Investigators. Lancet. 1999;354(9180):708-715.
3. Fox KAA, Poole-Wilson PA, Henderson RA, et al. Interventional versus conservative treatment for patients with unstable angina or non-ST elevation myocardial infarction: The British Heart Foundation RITA 3 randomised trial. Lancet. 2002;360(9335):743.
4. Mahoney EM, Jurkovitz CT, Chu H, et al. Cost and cost-effectiveness of an early invasive vs conservative strategy for the treatment of unstable angina and non-ST segment elevation myocardial infarction. JAMA. 2002;288(15):1851- 1858. (Pubitemid 35168140)
5. Van de Werf F, Bax J, Betriu A, et al. Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: The Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J. 2008;29(23):2909-2945.
6. Bassand JP, Hamm CW, Ardissino D, et al. Guidelines for the diagnosis and treatment of non-ST segment elevation acute coronary syndromes. Eur Heart J. 2007;28(13):1598-1660.
7. Hvelplund A, Galatius S, Madsen M, et al. Women with acute coronary syndrome are less invasively examined and subsequently less treated than men. Eur Heart J. 2010;31(6):684-690.
8. Freemantle N, Cleland J, Young P, et al. beta Blockade after myocardial infarction: systematic review and meta regression analysis. BMJ. 1999;318(7200):1730-1737. (Pubitemid 29290470)
9. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ. 2002;324(7329):71-86.
10. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: A randomised placebo-controlled trial. Lancet. 2002;360(9326):7-22.
11. Berger JS, Elliott L, Gallup D, et al. Sex differences in mortality following acute coronary syndromes. JAMA. 2009;302(8):874-882.
12. Halvorsen S, Eritsland J, Abdelnoor M, et al. Gender differences in management and outcome of acute myocardial infarctions treated in 2006-2007. Cardiology. 2009;114(2):83-88.
13. Nguyen JT, Berger AK, Duval S, et al. Gender disparity in cardiac procedures and medication use for acute myocardial infarction. Am Heart J. 2008;155(5):862-868.
14. Dey S, Flather MD, Devlin GP, et al. Sex-related differences in the presentation, treatment and outcomes among patients with acute coronary syndromes. The Global Registry of Acute Coronary Events. Heart. 2009;95(1):20-26. Epub 2008 May 7.
15. Reina A, Colmenero M, Aguayo de Hoyos E, et al. Gender differences in management and outcome of patients with acute myocardial infarction. Int J Cardiol. 2007;116(3):389-395. (Pubitemid 46283018)
16. Radovanovic D, Erne P, Urban P, Bertel O, Rickli H, Gaspoz JM; AMIS Plus Investigators. Gender differences in management and outcomes in patients with acute coronary yndromes: Results on 20,290 patients from the AMIS Plus Registry. Heart. 2007;93(11):1369-1375. (Pubitemid 351484789)
17. Milcent C, Dormont B, Durand-Zaleski I, Steg PG. Gender differences in hospital mortality and use of percutaneous coronary intervention in acute myocardial infarction: microsimulation analysis of the 1999 nationwide French hospitals database. Circulation. 2007;115(7):833-839.
18. Gislason GH, Rasmussen JN, Abildstrom SZ, et al. Long-term compliance with betablockers, angiotensin-converting enzyme inhibitors, and statins after acute myocardial infarction. Eur Heart J. 2006;27(10):1153-1158.
19. Heer T, Schiele R, Schneider S, et al. Gender differences in acute myocardial infarction in the era of reperfusion (the MITRA registry). Am J Cardiol. 2002;89(5):511-517. (Pubitemid 34178559)
20. Andersen TF, Madsen M, Jørgensen J, Mellemkjoer L, Olsen JH. The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan Med Bull. 1999;46(3):263-268. (Pubitemid 29299976)
21. Abildstrøm SZ, Kruse M, Rasmussen S, Madsen JK, Nielsen PH, Madsen M; Danish Heart Registry. [The Danish Heart Registry - a clinical database]. Ugeskr Laeger. 2008;170(7):532-536.
22. Gaist D, Sorensen HT, Hallas J. The Danish prescription registries. Dan Med Bull. 1997;44(4):445-448. (Pubitemid 27382061)
23. Pedersen CB, Gotzsche H, Moller JO, et al. The Danish Civil Registration System. A cohort of eight million persons. Dan Med Bull. 2006;53(4):441-449. (Pubitemid 44816920)
24. Rasmussen JN, Rasmussen S, Gislason GH, et al. Persistent socio-economic differences in revascularization after acute myocardial infarction despite a universal health care system - a Danish study. Cardiovasc Drugs Ther. 2007;21(6):449-457. (Pubitemid 350231512)
25. Madsen M, Davidsen M, Rasmussen S, Abildstrom SZ, Osler M. The validity of the diagnosis of acute myocardial infarction in routine statistics: A comparison of mortality and hospital discharge data with the Danish MONICA registry. J Clin Epidemiol. 2003;56(2):124-130. (Pubitemid 36315938)
26. Nielsen KM, Foldspang A, Larsen ML, Gerdes LU, Rasmussen S, Faergeman O. Estimating the incidence of the acute coronary syndrome: data from a Danish cohort of 138 290 persons. EurJ Cardiovasc Prev Rehabil. 2007;14(5):608-614. (Pubitemid 47556396)
27. Joensen AM, Jensen MK, Overvad K, et al. Predictive values of acute coronary syndrome discharge diagnoses differed in the Danish National Patient Registry. J Clin Epidemiol. 2009;62(2):188-194.
28. Rasmussen S, Zwisler AD, Abildstrom SZ, Madsen JK, Madsen M. Hospital variation in mortality after first acute myocardial infarction in Denmark from 1995 to 2002: lower short-term and 1-year mortality in high-volume and specialized hospitals. Med Care. 2005;43(10):970-978. (Pubitemid 41442462)
29. Tu JV, Austin PC, Walld R, et al. Development and validation of the Ontario acute myocardial infarction mortality prediction rules. J Am Coll Cardiol. 2001;37(4):992-997. (Pubitemid 32217595)
30. So L, Evans D, Quan H. ICD-10 coding algorithms for defining comorbidities of acute myocardial infarction. BMC Health Serv Res. 2006;6:161.
31. Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc. 1999;94:496-509.
32. MacIntyre K, Stewart S, Capewell S, et al. Gender and survival: A population-based study of 201,114 men and women following a first acute myocardial infarction. J Am Coll Cardiol. 2001;38(3):729-735. (Pubitemid 32835744)
33. Chang WC, Kaul P, Westerhout CM, et al. Impact of sex on long-term mortality from acute myocardial infarction vs unstable angina. Arch Intern Med. 2003;163(20):2476-2484. (Pubitemid 37385790)
34. Lee JH, Yang DH, Park HS, et al. Suboptimal use of evidence-based medical therapy in patients with acute myocardial infarction from the Korea Acute Myocardial Infarction Registry: prescription rate, predictors, and prognostic value. Am Heart J. 2010;159(6):1012-1019.
35. Yan AT, Yan RT, Tan M, et al. Optimal medical therapy at discharge in patients with acute coronary syndromes: Temporal changes, characteristics, and 1-year outcome. Am Heart J. 2007;154(6):1108-1115.(Pubitemid 350123528)